Jeffrey Scharfstein

Selected Transactions:

• SolarWinds Corporation (NYSE: SWI) in its sale to Turn/River Capital for $4.4 billion
• Silicon Labs (Nasdaq: SLAB) in the sale to Skyworks Solutions (NASAQ: SWKS) of its infrastructure and automotive business for $2.75 billion
• Luminex Corporation (NASDAQ: LMNX) in its sale to an Italian publicly traded company for $1.8 billion
• Alimera Sciences (NASDAQ: ALIM) in its sale to ANI Pharmaceuticals (NASDAQ: ANIP) for approximately $430 million
• Aetna (NYSE: AET) in its sale to CVS Health (NYSE: CVS) for $69 billion and related DOJ-mandated divestiture
• Silver Spike Acquisition Corp. (NASDAQ: SSPK), a special purpose acquisition vehicle, in its $1.5 billion combination with WMH Holdings
• Emerson Electric (NYSE: EMR) in its $3.1 billion acquisition of the valves and controls business of Pentair and a related FTC-mandated divestiture
• Symphony Technology Group-led consortium in its $2.1 billion acquisition of the RSA software security business from Dell Technologies
• A financial holding company in its sale of its ownership interest in an asset manager for consideration in excess of $2 billion
• Lionheart III Corp, a special purpose acquisition company, in its $360 million merger with Security Matters Limited, a publicly traded company on the Australian Securities Exchange
• N-able, Inc. (NYSE: NABL) in its acquisition of Adlumin, Inc. for approximately $270 million
  Peak Bio (OTC: PKBO) in its merger of equals with Akari Therapeutics, Plc (NASDAQ: AKTX)
• Q2 (Nasdaq: QTWO) in its acquisition of ClickSWITCH
• RateGenius in its business combination with AUTOPAY and formation of The Savings Group
• Peak Rock Capital and its portfolio company, Ziyad Brothers, in various transactions
• Safeguard Global in its acquisition of Global Upside Corporation
• BoomTown in its sale to Inside Real Estate
• Netwrix in its strategic investment from Centerbridge Partners
• Echo Investment Capital and its affiliates in various transactions
• Tailwind Capital and its portfolio companies in connection with various private equity acquisitions and investments
• ORIX Capital Partners in connection with various private equity acquisitions and investments
• ECI Telecom Group in its merger with Ribbon Communications
• Signify Health (NYSE: SGFY) in connection with various strategic matters, including acquisitions and commercial arrangements
• Pattern Energy in connection with its acquisition of renewable energy projects and related joint ventures
• Various financial advisor engagements, including representing Morgan Stanley, Dyal and Evercore as advisors to Bristol Myers Squibb in connection with its $74 billion acquisition of Celgene